Generated by Llama 3.3-70B| breast cancer | |
|---|---|
| Name | Breast cancer |
| Diseasesdb | 1598 |
| Icd10 | C50 |
| Icd9 | 174-175 |
breast cancer is a complex and multifaceted disease that affects millions of people worldwide, including Angelina Jolie, Sheryl Crow, and Giuliana Rancic. It is a leading cause of death among women, with a significant impact on American Cancer Society, National Cancer Institute, and World Health Organization. The disease has been extensively studied by researchers such as Dr. Susan Love, Dr. Eric Winer, and Dr. Larry Norton, who have made significant contributions to our understanding of the disease. Organizations like Susan G. Komen for the Cure, American Society of Clinical Oncology, and European Society for Medical Oncology have also played a crucial role in promoting awareness and funding research.
Breast cancer is a type of cancer that originates in the breast tissue of women and men, with Barack Obama and Joe Biden having lost loved ones to the disease. The exact causes of breast cancer are still not fully understood, but research has identified several key factors, including genetics, hormonal imbalance, and environmental factors, as studied by National Institute of Environmental Health Sciences and International Agency for Research on Cancer. For example, BRCA1 and BRCA2 gene mutations, which affect Ashkenazi Jews and other populations, increase the risk of developing breast cancer, as noted by National Breast Cancer Coalition and Genetic Alliance. Additionally, radiation exposure, such as that experienced by Chernobyl disaster survivors, can also contribute to the development of breast cancer, as reported by World Health Organization and International Commission on Radiological Protection.
The symptoms of breast cancer can vary widely, but common signs include a lump or mass in the breast, nipple discharge, and changes in breast size or shape, as described by American Cancer Society and National Cancer Institute. Diagnosis typically involves a combination of clinical examination, mammography, and biopsy, as recommended by American College of Radiology and College of American Pathologists. Ultrasound and MRI may also be used to confirm the diagnosis, as noted by Society of Breast Imaging and International Society for Magnetic Resonance in Medicine. Researchers like Dr. Etta Pisano and Dr. Carl D'Orsi have made significant contributions to the development of breast cancer diagnosis and imaging techniques, with support from organizations like National Institutes of Health and Department of Defense.
There are several types of breast cancer, including ductal carcinoma, lobular carcinoma, and inflammatory breast cancer, as classified by World Health Organization and American Joint Committee on Cancer. The disease can also be staged, with stage 0 indicating non-invasive cancer and stage IV indicating metastatic disease, as described by National Cancer Institute and American Cancer Society. Tumor grade and hormone receptor status are also important factors in determining the type and stage of breast cancer, as noted by College of American Pathologists and American Society of Clinical Oncology. Researchers like Dr. Monica Morrow and Dr. Clifford Hudis have made significant contributions to our understanding of breast cancer types and stages, with support from organizations like Breast Cancer Research Foundation and Komen for the Cure.
Treatment for breast cancer typically involves a combination of surgery, chemotherapy, and radiation therapy, as recommended by National Comprehensive Cancer Network and American Society of Clinical Oncology. Hormone therapy and targeted therapy may also be used, as noted by American Cancer Society and National Cancer Institute. Researchers like Dr. Larry Norton and Dr. Eric Winer have made significant contributions to the development of breast cancer treatments, with support from organizations like National Institutes of Health and Pharmaceutical Research and Manufacturers of America. Additionally, clinical trials and palliative care play important roles in the management of breast cancer, as described by National Cancer Institute and American Society of Clinical Oncology.
Breast cancer is a significant public health concern, with over 2.3 million new cases diagnosed worldwide each year, as reported by International Agency for Research on Cancer and World Health Organization. The disease affects women of all ages, but the risk increases with age, as noted by National Cancer Institute and American Cancer Society. Family history, genetic mutations, and reproductive factors are also important risk factors, as studied by National Institute of Environmental Health Sciences and Centers for Disease Control and Prevention. Researchers like Dr. Brian Henderson and Dr. Leslie Bernstein have made significant contributions to our understanding of breast cancer epidemiology and risk factors, with support from organizations like National Institutes of Health and American Cancer Society.
The prognosis for breast cancer varies widely depending on the type and stage of the disease, as noted by National Cancer Institute and American Cancer Society. Generally, early-stage breast cancer has a good prognosis, with 5-year survival rates exceeding 90%, as reported by American Cancer Society and National Cancer Institute. However, metastatic breast cancer has a poorer prognosis, with 5-year survival rates ranging from 20-30%, as described by National Cancer Institute and American Society of Clinical Oncology. Researchers like Dr. Gabriel Hortobagyi and Dr. George Sledge have made significant contributions to our understanding of breast cancer prognosis and outcomes, with support from organizations like National Institutes of Health and Breast Cancer Research Foundation. Category:Cancer